Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Index funds distribute capital gains at occasional dates; knowing when helps you coordinate withdrawals and tax planning effectively.
25,550 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Imagine a world where your phone pays you back for every scroll and tap. This article dives into Mode Mobile, a specu...
When a crypto-focused firm makes a substantial equity bet in a media company, it can signal strategic confidence—and ...
Lithium Americas has gained 32% in the last year as Thacker Pass advances, but rising share dilution and mounting cap...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...
Strategy, the world’s largest Bitcoin holder, quietly added to its treasury last week, acquiring just over 1,000 BTC ...
GM authorized a $6 billion buyback and boosted its dividend, signaling a shift toward disciplined cash returns. Ford,...
Tech insiders are stepping up their open-market purchases in software, chipmakers, and AI platforms, reviving a contr...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...